Fukutin anticorps (AA 222-456)
Aperçu rapide pour Fukutin anticorps (AA 222-456) (ABIN1886220)
Antigène
Voir toutes Fukutin (FKTN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 222-456
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 222 and 456 of Human FKTN
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- Fukutin (FKTN)
-
Autre désignation
- fukutin
-
Sujet
-
The protein encoded by this gene is a putative transmembrane protein that is localized to the cis-Golgi compartment, where it may be involved in the glycosylation of alpha-dystroglycan in skeletal muscle.The encoded protein is thought to be a glycosyltransferase and could play a role in brain development.Defects in this gene are a cause of Fukuyama-type congenital muscular dystrophy (FCMD), Walker-Warburg syndrome (WWS), limb-girdle muscular dystrophy type 2M (LGMD2M), and dilated cardiomyopathy type 1X (CMD1X).Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq]
-
Poids moléculaire
- 54 kDa
-
ID gène
- 2218
-
NCBI Accession
- NM_006731, NP_006722
-
Pathways
- Regulation of Carbohydrate Metabolic Process
Antigène
-